Invention Grant
- Patent Title: In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
-
Application No.: US16220014Application Date: 2018-12-14
-
Publication No.: US11300569B2Publication Date: 2022-04-12
- Inventor: Jerome Galon , Franck Pages , Wolf-Herman Fridman
- Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM) , Universite Paris Descartes
- Applicant Address: FR Paris; FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM),Universite Paris Descartes
- Current Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM),Universite Paris Descartes
- Current Assignee Address: FR Paris; FR Paris
- Agency: WCF IP
- Priority: EP05292200 20051019
- Main IPC: G01N33/574
- IPC: G01N33/574 ; C12Q1/6886
Abstract:
The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer.
Public/Granted literature
Information query
IPC分类:
